Intravenous Tirofiban After Tenecteplase in Acute Ischemic Stroke

Key Points

• The aim is to assess the effects of tirofiban on functional outcomes in acute ischemic stroke patients who do not respond adequately to tenecteplase.
• Evaluated patients with acute ischemic stroke without large or medium vessel occlusion.
• Included only those with inadequate response to tenecteplase.
• Designed as a randomized trial to analyze treatment efficacy.
• Tirofiban improved functional outcomes compared to control in patients receiving tenecteplase.
• Significant improvement was noted, confirming the benefit of adjunctive therapy.
• Further details on effect size and statistical significance were not provided.